- #ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this yearRoche says it has one obesity drug with a potential best-in-class safety profile, and another with a similar shot at leading in efficacy. Combining them could produce a highly successful product if…Endpoints · 1mo ago↗ source
- Lawmakers propose China restrictions; #ASCO26 recap; and moreWelcome back to Endpoints Weekly! We had a small team in Chicago last weekend at this year’s ASCO conference. You’ll find a recap of their coverage below, including more details on Revolution Medic…Endpoints · 1mo ago↗ source
- #ADA26: Roche's incretin shot works in mid-stage trial in type 1 diabetesA daily incretin shot being developed by Roche has shown promise in type 1 diabetes — the form that is not generally believed to be directly treatable by GLP-1-based drugs. According to Phase 2 d…